nach oben

Erschienen in:

01.01.2017 | Original Paper

Green tea cultivar ‘Benifuuki’ potentiates split vaccine-induced immunoglobulin A production

verfasst von: Yeong-Seon Won, Motofumi Kumazoe, Kanako Takamatsu, Yuki Shinoda, Saki Sonoda, Kenji Okada, Takehisa Okamoto, Hirofumi Tachibana

Erschienen in: Journal of Natural Medicines | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Influenza is a widespread disease caused by infection with the influenza virus. Vaccination is considered to be the main countermeasure against influenza. A split vaccine is widely used to avoid severe adverse events, and it induces strong humoral immunity. However, the split vaccine alone cannot elicit mucosal immunity, including IgA production, and its preventative effects are limited. Here, we show that the green tea cultivar ‘Benifuuki’ extract enhanced the effect of a split vaccine on mucosal immunity. The frequency of IgA⁺ cells was increased in lung and Peyer’s patch that received Benifuuki diet. Secretion of hemagglutinin-specific mucosal IgA, which is closely linked to the prevention of viral infection, was significantly increased in the bronchoalveolar lavage fluid of split vaccine-immunized BALB/c mice that were administered green tea Benifuuki extract. Our findings suggest that Benifuuki intake enhanced the effects of the split vaccine on mucosal immunity.

Nur mit Berechtigung zugänglich

Centers for Disease Control and Prevention (CDC) (2010) Estimates of deaths associated with seasonal influenza—United States, 1976–2007. MMWR Morb Mortal Wkly Rep 59:1057–1062

Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179–186CrossRefPubMed

Koyama S, Aoshi T, Tanimoto T, Kumagai Y, Kobiyama K, Tougan T, Sakurai K, Coban C, Horii T, Akira S, Ishii KJ (2010) Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci Transl Med 2:25ra24CrossRefPubMed

Wong SS, Webby RJ (2013) Traditional and new influenza vaccines. Clin Microbiol Rev 26:476–492CrossRefPubMedPubMedCentral

Chen D, Periwal SB, Larrivee K, Zuleger C, Erickson CA, Endres RL, Payne LG (2001) Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization. J Virol 75:7956–7965CrossRefPubMedPubMedCentral

Mantis NJ, Rol N, Corthésy B (2011) Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 4:603–611CrossRefPubMedPubMedCentral

Proudfoot O, Esparon S, Tang CK, Laurie K, Barr I, Pietersz G (2015) Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung. BMC Infect Dis 15:101CrossRefPubMedPubMedCentral

Le TV, Mironova E, Garcin D, Compans RW (2011) Induction of influenza-specific mucosal immunity by an attenuated recombinant Sendai virus. PLoS One 6:e18780CrossRefPubMedPubMedCentral

Fagarasan S, Honjo T (2003) Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 3:63–72CrossRefPubMed

10.

Dougan SK, Ashour J, Karssemeijer RA, Popp MW, Avalos AM, Barisa M, Altenburg AF, Ingram JR, Cragnolini JJ, Guo C, Alt FW, Jaenisch R, Ploegh HL (2013) Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus. Nature 503:406–409CrossRefPubMedPubMedCentral

11.

Imai K, Suga K, Nakachi K (1997) Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 26:769–775CrossRefPubMed

12.

Baba Y, Sonoda JI, Hayashi S, Tosuji N, Sonoda S, Makisumi K, Nakajo M (2012) Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy. Exp Ther Med 4:452–458CrossRefPubMedPubMedCentral

13.

Stoicov C, Saffari R, Houghton J (2009) Green tea inhibits Helicobacter growth in vivo and in vitro. Int J Antimicrob Agents 33:473–478CrossRefPubMedPubMedCentral

14.

Kim YJ, Houng SJ, Kim JH, Kim YR, Ji HG, Lee SJ (2012) Nanoemulsified green tea extract shows improved hypocholesterolemic effects in C57BL/6 mice. J Nutr Biochem 23:186–191CrossRefPubMed

15.

Yung LM, Leung FP, Wong WT, Tian XY, Yung LH, Chen ZY, Yao XQ, Huang Y (2008) Tea polyphenols benefit vascular function. Inflammopharmacology 16:230–234CrossRefPubMed

16.

Hotta Y, Huang L, Muto T, Yajima M, Miyazeki K, Ishikawa N, Fukuzawa Y, Wakida Y, Tushima H, Ando H, Nonogaki T (2006) Positive inotropic effect of purified green tea catechin derivative in guinea pig hearts: the measurements of cellular Ca2⁺ and nitric oxide release. Eur J Pharmacol 552:123–130CrossRefPubMed

17.

Marathe SA, Datey AA, Chakravortty D (2012) Herbal cocktail as anti-infective: promising therapeutic for the treatment of viral diseases. Recent Pat Antiinfect Drug Discov 7:123–132CrossRefPubMed

18.

Tsukamoto S, Huang Y, Umeda D, Yamada S, Yamashita S, Kumazoe M, Kim Y, Murata M, Yamada K, Tachibana H (2014) 67-kDa laminin receptor-dependent protein phosphatase 2A (PP2A) activation elicits melanoma-specific antitumor activity overcoming drug resistance. J Bio Chem 289:32671–32681CrossRef

19.

Suzuki T, Kumazoe M, Kim Y, Yamashita S, Nakahara K, Tsukamoto S, Sasaki M, Hagihara T, Tsurudome Y, Huang Y, Maeda-Yamamoto M, Shinoda Y, Yamaguchi W, Yamada K, Tachibana H (2013) Green tea extract containing a highly absorbent catechin prevents diet-induced lipid metabolism disorder. Sci Rep 3:2749CrossRefPubMedPubMedCentral

20.

Yoshino K, Miyase T, Sano M (2010) Preventive effects of C-2 epimeric isomers of tea catechins on mouse type I allergy. J Nutr Sci Vitaminol (Tokyo) 56:211–215CrossRef

21.

Persson IA, Josefsson M, Persson K, Andersson RG (2006) Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J Pharm Pharmacol 58:1139–1144CrossRefPubMed

22.

Maeda-Yamamoto M, Ema K, Tokuda Y, Monobe M, Tachibana H, Sameshima Y, Kuriyama S (2011) Effect of green tea powder (Camellia sinensis L. cv. Benifuuki) particle size on O-methylated EGCG absorption in rats; The Kakegawa Study. Cytotechnology 63:171–179CrossRefPubMedPubMedCentral

23.

Maeda-Yamamoto M, Ema K, Monobe M, Tokuda Y, Tachibana H (2012) Epicatechin-3-O-(3″-O-methyl)-gallate content in various tea cultivars (Camellia sinensis L.) and its in vitro inhibitory effect on histamine release. J Agric Food Chem 60:2165–2170CrossRefPubMed

24.

Kurita I, Maeda-Yamamoto M, Tachibana H, Kamei M (2010) Antihypertensive effect of Benifuuki tea containing O-methylated EGCG. J Agric Food Chem 58:1903–1908CrossRefPubMed

25.

Maeda-Yamamoto M, Ema K, Shibuichi I (2007) In vitro and in vivo anti-allergic effects of ‘benifuuki’ green tea containing O-methylated catechin and ginger extract enhancement. Cytotechnology 55:135–142CrossRefPubMedPubMedCentral

26.

Maeda-Yamamoto M, Ema K, Monobe M, Shibuichi I, Shinoda Y, Yamamoto T, Fujisawa T (2009) The efficacy of early treatment of seasonal allergic rhinitis with benifuuki green tea containing O-methylated catechin before pollen exposure: an open randomized study. Allergol Int 58:437–444CrossRefPubMed

27.

Albu DI, Jones-Trower A, Woron AM, Stellrecht K, Broder CC, Metzger DW (2003) Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins. J Virol 77:5589–5597CrossRefPubMedPubMedCentral

28.

van Riet E, Ainai A, Suzuki T, Hasegawa H (2012) Mucosal IgA responses in influenza virus infections; thoughts for vaccine design. Vaccine 30:5893–5900CrossRefPubMed

29.

Cao W, Liu YJ (2007) Innate immune functions of plasmacytoid dendritic cells. Curr Opin Immunol 19:24–30CrossRefPubMed

30.

Stöhr K (2002) Influenza—WHO cares. Lancet Infect Dis 2:517CrossRefPubMed

31.

Nichol KL, Treanor JJ (2006) Vaccines for seasonal and pandemic influenza. J Infect Dis 194:S111–S118CrossRefPubMed

32.

Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ (2008) The global circulation of seasonal influenza A (H3N2) viruses. Science 320:340–346CrossRefPubMed

33.

Durham MD, Buchacz K, Armon C, Patel P, Wood K, Brooks JT; HIV Outpatient Study (HOPS) Investigators (2015) Seasonal influenza vaccination rates in the HIV outpatient study—United States, 1999–2013. Clin Infect Dis 60:976–977CrossRefPubMed

34.

Weber C, Sliva K, von Rhein C, Kümmerer BM, Schnierle BS (2015) The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection. Antiviral Res 113:1–3CrossRefPubMed

35.

Huang HC, Tao MH, Hung TM, Chen JC, Lin ZJ, Huang C (2014) (−)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes. Antiviral Res 111:100–111CrossRefPubMed

36.

Ahmed M, Henson DA, Sanderson MC, Nieman DC, Gillitt ND, Lila MA (2014) The protective effects of a polyphenol-enriched protein powder on exercise-induced susceptibility to virus infection. Phytother Res 28:1829–1836CrossRefPubMed

37.

Pang JY, Zhao KJ, Wang JB, Ma ZJ, Xiao XH (2014) Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro. J Zhejiang Univ Sci B 15:533–539CrossRefPubMedPubMedCentral

38.

Kim M, Kim SY, Lee HW, Shin JS, Kim P, Jung YS, Jeong HS, Hyun JK, Lee CK (2013) Inhibition of influenza virus internalization by (−)-epigallocatechin-3-gallate. Antiviral Res 100:460–472CrossRefPubMed

39.

Suzuki Y (2005) Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 28:399–408CrossRefPubMed

40.

Kuno-Sakai H, Kimura M, Ohta K, Shimojima R, Oh Y, Fukumi H (1994) Developments in mucosal influenza virus vaccines. Vaccine 12:1303–1310CrossRefPubMed

41.

Sawaengsak C, Mori Y, Yamanishi K, Mitrevej A, Sinchaipanid N (2014) Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine. AAPS PharmSciTech 15:317–325CrossRefPubMed

42.

de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K (2012) Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. Vaccine 30:4884–4891CrossRefPubMed

43.

Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A (2009) Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206:79–87CrossRefPubMedPubMedCentral

Titel: Green tea cultivar ‘Benifuuki’ potentiates split vaccine-induced immunoglobulin A production
verfasst von: Yeong-Seon Won
Motofumi Kumazoe
Kanako Takamatsu
Yuki Shinoda
Saki Sonoda
Kenji Okada
Takehisa Okamoto
Hirofumi Tachibana
Publikationsdatum: 01.01.2017
Verlag: Springer Japan
Erschienen in: Journal of Natural Medicines / Ausgabe 1/2017
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI: https://doi.org/10.1007/s11418-016-1028-7

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Green tea cultivar ‘Benifuuki’ potentiates split vaccine-induced immunoglobulin A production

Abstract

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Protein tyrosine phosphatase 1B inhibitory properties of seco-cucurbitane triterpenes obtained from fruiting bodies of Russula lepida

Three new ent-kaurane diterpenes from the herbs of Wedelia prostrata

Application of a quantitative 1H-NMR (1H-qNMR) method for the determination of geniposidic acid and acteoside in Plantaginis semen

Hypocholesterolemic effect of sericin-derived oligopeptides in high-cholesterol fed rats

Quantitative evaluation and discrimination of wild Paris polyphylla var. yunnanensis (Franch.) Hand.-Mazz from three regions of Yunnan Province using UHPLC–UV–MS and UV spectroscopy couple with partial least squares discriminant analysis

Ginsenosides, ingredients of the root of Panax ginseng, are not substrates but inhibitors of sodium-glucose transporter 1